Norepinephrine is used to treat severe low blood pressure, typically in hospital settings when other treatments haven't worked. It works by narrowing blood vessels and strengthening the heart's contractions to increase blood pressure.[2] Levophed is currently approved and in use across 41 indications[4].[1]
Levophed is one of 896 small molecule programs targeting Cardiovascular Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Levophed
Adriamycin
Gemzar
Megace
Cymbalta
Methylthioninium Chloride
Vfend
QS21
Motexafin Gadolinium
Perflutren Lipid Microsphere
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details